NCT05292664 2026-03-12
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Dana-Farber Cancer Institute
Phase 1 Recruiting
Dana-Farber Cancer Institute
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Gruppo Italiano Malattie EMatologiche dell'Adulto
University Hospital Muenster
University of Wuerzburg